EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Go back to EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients| Regeneron (NASDAQ: REGN) | Delayed: 827.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $827.72 | 52 Week High | $592.36 | |||
| Open | $827.72 | 52 Week Low | $325.35 | |||
| Day High | $827.72 | P/E | 217.25 | |||
| Day Low | $827.72 | EPS | $3.81 | |||
| Volume | 100 | |||||

